O-linked glycosylation in focus

O-linked glycosylation in focus

Important progress has been made recently in the development of analytical technology for O-linked oligosaccharide structure determination. Methods were developed for the chemical release (and subsequent labeling) of O-linked glycans from glycoproteins, e.g. by β-elimination or by hydrazinolysis. Di...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Van den Steen, P, Rudd, P, Wormald, M, Dwek, R, Opdenakker, G
Format:	Journal article
Język:	Japanese
Wydane:	2000

Podobne zapisy

Matrix remodelling enzymes, the protease cascade and glycosylation.
od: Van den Steen, P, i wsp.
Wydane: (2001)

Differential glycosylation of gelatinase B from neutrophils and breast cancer cells.
od: Fry, SA, i wsp.
Wydane: (2005)

Glycosylation and prion protein.
od: Rudd, P, i wsp.
Wydane: (2002)

Remnant epitopes, autoimmunity and glycosylation.
od: Opdenakker, G, i wsp.
Wydane: (2006)

Exploring functions for glycosylation in host defence using novel oligosaccharide sequencing technology
od: Rudd, P, i wsp.
Wydane: (2000)

The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
od: Van den Steen, P, i wsp.
Wydane: (2006)

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.
od: Saldova, R, i wsp.
Wydane: (2008)

Structural aspects of glycomes with a focus on N-glycosylation and glycoprotein folding.
od: Petrescu, A, i wsp.
Wydane: (2006)

The impact of glycosylation on the biological function and structure of human immunoglobulins.
od: Arnold, J, i wsp.
Wydane: (2007)

Roles for glycosylation in the anti-inflammatory molecule CD59.
od: Rudd, P, i wsp.
Wydane: (1997)

Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
od: Butters, T, i wsp.
Wydane: (2000)

The glycosylation of the complement regulatory protein, human erythrocyte CD59.
od: Rudd, P, i wsp.
Wydane: (1998)

The glycosylation of the complement regulatory protein, human erythrocyte CD59.
od: Rudd, P, i wsp.
Wydane: (1997)

Controlled glycosylation of therapeutic antibodies in plants.
od: Tekoah, Y, i wsp.
Wydane: (2004)

Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells.
od: Rudd, P, i wsp.
Wydane: (2000)

O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme.
od: Mattu, T, i wsp.
Wydane: (2000)

Glycosylation influences the lectin activities of the mannose receptor
od: Yunpeng, Y, i wsp.
Wydane: (2005)

Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
od: Fry, SA, i wsp.
Wydane: (2006)

Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3
od: Fry, SA, i wsp.
Wydane: (2006)

Glycosylation influences the lectin activities of the macrophage mannose receptor.
od: Su, Y, i wsp.
Wydane: (2005)

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin.
od: Arnold, J, i wsp.
Wydane: (2005)

Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides.
od: Tsiftsoglou, SA, i wsp.
Wydane: (2006)

Direct deprotected glycosyl-asparagine ligation.
od: Doores, K, i wsp.
Wydane: (2006)

The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin.
od: Arnold, J, i wsp.
Wydane: (2004)

Glycoproteins: rapid sequencing technology for N-linked and GPI anchor glycans
od: Rudd, P, i wsp.
Wydane: (1999)

Sugar-mediated ligand-receptor interactions in the immune system.
od: Rudd, P, i wsp.
Wydane: (2004)

Glycosylation: disease targets and therapy.
od: Zitzmann, N, i wsp.
Wydane: (2005)

Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding.
od: Petrescu, A, i wsp.
Wydane: (2004)

Glycosylation markers for cancer diagnosing and monitoring
od: Dwek, R, i wsp.
Wydane: (2006)

Glycosylation influences the ligand binding activities of mannose receptor.
od: Su, Y, i wsp.
Wydane: (2005)

Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody.
od: Jacquemin, M, i wsp.
Wydane: (2006)

Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.
od: Royle, L, i wsp.
Wydane: (2003)

Prion glycoprotein: structure, dynamics, and roles for the sugars.
od: Rudd, P, i wsp.
Wydane: (2001)

Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control.
od: Branza-Nichita, N, i wsp.
Wydane: (2000)

Targeting glycosylation as a therapeutic approach.
od: Dwek, R, i wsp.
Wydane: (2002)

Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.
od: Crispin, M, i wsp.
Wydane: (2006)

"Internal residue loss": rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus.
od: Harvey, D, i wsp.
Wydane: (2002)

Altered O-linked glycosylation in benign and malignant meningiomas
od: Chutima Talabnin, i wsp.
Wydane: (2024-01-01)

Emerging principles for the therapeutic exploitation of glycosylation.
od: Dalziel, M, i wsp.
Wydane: (2014)

Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells.
od: Wheeler, S, i wsp.
Wydane: (2002)